Physician profile
Mark Godish
NPI 1689632937
$10,709.68
in general payments reported to CMS, 2019-2025
50 companies · $2,155 in 2025
The $2,155 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $841 · 2021: $1,173 · 2022: $1,714 · 2023: $1,603 · 2024: $2,004 · 2025: $2,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,655 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,655.13 |
| Education | $106.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $1,373.33 | 2019-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $1,216.49 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,018.03 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $943.75 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Genzyme Corporation | $808.28 | 2019-2025 | |
| Baxter Healthcare | $600.41 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System, Hillrom - Volara System |
| Fisher & Paykel Healthcare INC | $468.28 | 2022-2025 | Fisher & Paykel Healthcare |
| Novartis Pharmaceuticals Corporation | $378.11 | 2019-2025 | |
| Inspire Medical Systems, INC. | $358.59 | 2023-2025 | Inspire |
| Inogen, INC. | $289.81 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genentech USA, INC. | $229.20 | 2019-2024 | Xolair |
| Actelion Pharmaceuticals US, INC. | $223.86 | 2019-2025 | Uptravi |
| Amgen INC. | $200.57 | 2021-2025 | Tezspire |
| Sunovion Pharmaceuticals INC. | $193.39 | 2019 | |
| Allergan, INC. | $180.82 | 2019-2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $170.49 | 2020-2025 | Dupixent |
| Pfizer INC. | $148.35 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $140.34 | 2020-2024 | |
| Mallinckrodt Hospital Products INC. | $135.06 | 2021-2022 | |
| Gilead Sciences, INC. | $115.04 | 2021-2023 | |
| United Therapeutics Corporation | $114.82 | 2019-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $110.86 | 2020-2024 | Glassia |
| Merck Sharp & Dohme LLC | $110.37 | 2019-2024 | Winrevair |
| Axsome Therapeutics, INC. | $107.44 | 2022-2025 | Sunosi |
| Intuitive Surgical, INC. | $105.85 | 2025 | |
| Jazz Pharmaceuticals INC. | $96.62 | 2021-2025 | |
| Mylan Specialty L.P. | $81.46 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $69.70 | 2022-2025 | Wakix |
| Alexion Pharmaceuticals, INC. | $68.12 | 2019-2024 | Ultomiris |
| Janssen Pharmaceuticals, INC | $64.94 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $64.14 | 2020-2022 | |
| Vyera Pharmaceuticals, LLC | $56.98 | 2020-2021 | |
| Abbvie INC. | $51.90 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $49.66 | 2022-2024 | Purified Cortrophin Gel |
| Mayne Pharma Commercial LLC | $39.72 | 2020 | |
| Philips North America LLC | $33.44 | 2019-2025 | Vest Therapy Und |
| Pulmonx Corporation | $32.37 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Circassia INC. | $32.19 | 2020 | |
| Masimo Corporation | $29.08 | 2024 | |
| Paratek Pharmaceuticals, INC. | $23.71 | 2025 | Nuzyra |
| Avadel Cns Pharmaceuticals, LLC | $23.44 | 2025 | Lumryz |
| Boston Scientific Corporation | $21.50 | 2019 | |
| Lilly USA, LLC | $20.89 | 2025 | Zepbound |
| La Jolla Pharmaceutical Company | $18.52 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.33 | 2020 | |
| Inari Medical, INC. | $16.04 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Advanced Respiratory, INC | $15.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.31 | 2022 | |
| Phadia US INC. | $14.29 | 2024 | Immunocap |
| Verona Pharma, INC. | $13.69 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Godish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.